CoChat

Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence

Allison, C, Pratt, J.A · 2003 · Pharmacology & Therapeutics

The DOI matches its Crossref record; 240 of the 241 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

Knowledge of the neural mechanisms underlying the development of benzodiazepine (BZ) dependence remains incomplete. The gamma-aminobutyric acid (GABA(A)) receptor, being the main locus of BZ action, has been the main focus to date in studies performed to elucidate the neuroadaptive processes underlying BZ tolerance and withdrawal in preclinical studies. Despite this intensive effort, however, no clear consensus has been reached on the exact contribution of neuroadaptive processes at the level of the GABA(A) receptor to the development of BZ tolerance and withdrawal. It is likely that changes at the level of this receptor are inadequate in themselves as an explanation of these neuroadaptive processes and that neuroadaptations in other receptor systems are important in the development of BZ dependence. In particular, it has been hypothesised that as part of compensatory mechanisms to diazepam-induced chronic enhancement of GABAergic inhibition, excitatory mechanisms (including the glutamatergic system) become more sensitive [Behav. Pharmacol. 6 (1995) 425], conceivably contributing to BZ tolerance development and/or expression of withdrawal symptoms on cessation of treatment, including increased anxiety and seizure activity. Glutamate is a key candidate for changes in excitatory transmission mechanisms and BZ dependence, (1) since there are defined neuroanatomical relationships between glutamatergic and GABAergic neurons in the CNS and (2) because of the pivotal role of glutamatergic neurotransmission in mediating many forms of synaptic plasticity in the CNS, such as long-term potentiation and kindling events. Thus, it is highly possible that glutamatergic processes are also involved in the neuroadaptive processes in drug dependence, which can conceivably be considered as a form of synaptic plasticity. This review provides an overview of studies investigating changes in the GABAergic and glutamatergic systems in the brain associated with BZ dependence, with particular attention to the possible differential involvement of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors in these processes.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0163-7258(03)00029-9

Cites

240 of 241 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 241 references

Research works printed but not linked: 5

  1. Allison, 1999, Alterations in AMPA receptor binding during withdrawal sensitisation from benzodiazepines, Behav Pharmacol, 10, S2
  2. Jeevanjee, 1985, Is FG7142 mediated kindling due to changes in efficacy at the BZ/GABA receptor complex?, Br J Pharmacol, 84, 188P
  3. Roca, 1990, Chronic agonist exposure induces downregulation and allosteric uncoupling of the GABA/benzodiazepine receptor complex, Mol Pharmacol, 37, 37
  4. Sloan, 1991, Duration of diazepam (dz) treatment and the intensity of flumazenil precipitated abstinence (fpa) in dogs, FASEB J, 5, 703
  5. Zhao, 1994, Reduced expression of GABAA/benzodiazepine receptor γ2 and α5 subunit mRNAs in brain regions of flurazepam treated rats, Mol Pharmacol, 45, 657

Cited by

See all 165

Metadata

Authors
Allison, C., & Pratt, J. A.
Affiliations
University of Strathclyde (GB)
Corresponding author
Pratt, J.A
Venue
Pharmacology & Therapeutics
Publisher
Elsevier BV
Published
2003-05
Volume
98
Issue
2
Pages
171-195
ISSN
0163-7258 (ISSN-L)
OpenAlex
W1969765270
Cited by
160
References
241
Citations by year
2026: 6 · 2025: 5 · 2024: 7 · 2023: 6 · 2022: 4 · 2021: 10 · 2020: 12 · 2018: 9 · 2017: 2 · 2016: 7 · 2015: 5 · 2014: 7 · 2013: 10 · 2012: 9
FWCI
0.64
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
Keywords
benzodiazepine dependence, neural adaptation, GABAA receptor, glutamatergic system, NMDA receptor, AMPA receptors, drug tolerance, withdrawal, synaptic plasticity, diazepam, excitation-inhibition balance
MeSH terms
Benzodiazepines, Humans, Neuronal Plasticity, Receptors, GABA-A, Substance Withdrawal Syndrome, Synaptic Membranes, Anti-Anxiety Agents, Receptors, N-Methyl-D-Aspartate, Receptors, Glutamate, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence. https://app.cochat.ai/papers/10.1016/s0163-7258(03)00029-9
The paper
Allison, C., & Pratt, J. A. (2003). Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence. Pharmacology & Therapeutics. https://doi.org/10.1016/s0163-7258(03)00029-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.